Strategic partnerships SkinVision has an active and growing partner ecosystem with healthcare providers and insurers (e.g., Mayo Clinic collaboration, Benenden Health, UniMed). This indicates a sales opportunity to target additional medical networks, insurers, and health plans that seek validated skin cancer screening integrations.

Healthcare integration Recent launches like SkinVision Pro and direct-connect platforms to medical practices show a push toward seamless clinical integration. A clear opportunity exists to offer API access, EHR/EMR integrations, or practice-management compatibility to accelerate adoption in clinics and health systems.

Scale through campaigns With over 3 million users and a scalable AI-based screening platform, there is potential to upsell to employer-sponsored health plans, wellness programs, and consumer health initiatives targeting skin health awareness and preventive care.

Regulatory validation Clinical validation and FDA-related collaboration efforts (Mayo Clinic partnership to support FDA requirements) create a credibility moat. This can be leveraged to pursue additional regulatory-aligned opportunities in the US and other regulated markets requiring validated AI-based screening.

Global expansion Multiple international partnerships and a UK-origin brand footprint indicate readiness for new regional partners and payor channels in Europe, Asia-Pacific, and North America, focusing on health plans and patient access programs seeking validated skin cancer screening.